Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mid-Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06958432
What this trial is testing

Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)

Who this might be right for
Rectal CancerNeoadjuvant TherapiesImmune Checkpoint Therapy+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 430
Not applicableLooking for participantsNCT07512232
What this trial is testing

Intraoperative Rectal Lavage to Prevent Local Recurrence After Laparoscopic Mid-to-Low Rectal Cancer Resection: A Multicenter Randomized Trial

Who this might be right for
Middle and Low Rectal CancerRectal Cancer Surgery
Sun Yat-sen University 1,598
Testing effectiveness (Phase 2)Looking for participantsNCT06204094
What this trial is testing

Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Jinhua Central Hospital 37
Not applicableLooking for participantsNCT02966483
What this trial is testing

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Who this might be right for
Rectal Neoplasms MalignantSurgery
Sun Yat-sen University 1,114
Not applicableUnknownNCT06566222
What this trial is testing

Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors

Who this might be right for
Radiotherapy
Changhai Hospital 2,000
Not applicableLooking for participantsNCT06194708
What this trial is testing

Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer （NORESTO Study）

Who this might be right for
Rectal Cancer
Peking Union Medical College Hospital 235
Not applicableStudy completedNCT03107650
What this trial is testing

Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer

Who this might be right for
Rectal Cancer
Pere Planellas Giné 323
Testing effectiveness (Phase 2)Study completedNCT03000374
What this trial is testing

Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery

Who this might be right for
Rectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 34
Testing effectiveness (Phase 2)Study completedNCT06493240
What this trial is testing

Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Peking University People's Hospital 30
Not applicableLooking for participantsNCT03573791
What this trial is testing

Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

Who this might be right for
Rectal CancerCancer of RectumCancer of the Rectum+4 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 152
Not applicableLooking for participantsNCT07605611
What this trial is testing

Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior Resection

Who this might be right for
Rectal CancerAnastomotic Leakage
Tongji Hospital 72
Testing effectiveness (Phase 2)Looking for participantsNCT05972655
What this trial is testing

Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer

Who this might be right for
Low Rectal Cancer
Sir Run Run Shaw Hospital 32
Not applicableNot Yet RecruitingNCT07189780
What this trial is testing

Comparison of Different Surgical Approaches in Female Rectal Cancer.

Who this might be right for
Rectal Cancer Surgery
First Affiliated Hospital of Wenzhou Medical University 200
Large-scale testing (Phase 3)Looking for participantsNCT04095299
What this trial is testing

Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients

Who this might be right for
Cancer of Rectum
Vejle Hospital 162
Not applicableNot Yet RecruitingNCT06823297
What this trial is testing

Can Neoadjuvant Chemoradiotherapy be Ommited in Mid-rectal Cancer

Who this might be right for
Mid-Rectal CancerRectal Cancer Stage IIRectal Cancer Stage III
Turkish Society of Colon and Rectal Surgery 436
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06760520
What this trial is testing

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
The First Affiliated Hospital of Zhengzhou University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07779694
What this trial is testing

16-Hour Fasting Plus Serplulimab and CAPEOX as Neoadjuvant Therapy in pMMR/MSS Advanced Mid-to-Low Rectal Cancer

Who this might be right for
pMMR/MSSLocally Advanced Rectal CarcinomaFasting, Intermittent
Zhejiang University 51
Not applicableNot Yet RecruitingNCT07761169
What this trial is testing

Randomized Controlled Trial of the SurgDiff Model for Predicting Surgical Difficulty to Help Choose Approach in Mid-Low Rectal Cancer

Who this might be right for
Rectal Cancer
Peking Union Medical College Hospital 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT06056804
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Beijing Friendship Hospital 20